Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K904181Substantially Equivalent

Anti-Gbm Antibodies Quantitative Kit

Biochemical Diagnostic, Inc., Sweden, SE / Traditional, Substantially Equivalent

K904181 is the FDA 510(k) clearance record for ANTI-GBM ANTIBODIES QUANTITATIVE KIT, a class II device, cleared for Biochemical Diagnostic, Inc. on under FDA product code DBL (Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control). FDA records list 5 510(k) clearances for Biochemical Diagnostic, Inc., from to . As of , FDA records show no recalls naming K904181.

Clearance record

Decision date
Received
(364 days to decision)
Product code
DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Regulation
21 CFR 866.5660
Device class
Class II
Review panel
Immunology
Applicant
Biochemical Diagnostic, Inc. S-223 70 Lund, Sweden, SE
Third party review
No

Clearances, product code DBL

Trailing 12 months

FDA records hold no clearances under product code DBL in the trailing twelve months.

FDA records show no clearances under product code DBL in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DBL, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260